“…Conversion of this parent triazole into the corresponding acyclic 1,u-bis(triazoles) 17e25/macrocyclic crown compounds 43, 44/or lariat macrocycles 46, 47, 49 enhanced the inhibitory effect against one or more type of the test organisms. Thus, compared to compound 15, compounds 19, 21, 23 (at concentrations 2.5e5.0 mg/mL) showed higher inhibitory effect against Aspergillus fumigatus RCMB 002008 (1), compounds 18, 19e22, 46 (at concentrations 1.0e5.0 mg/mL) showed higher inhibitory effect against Penicillium italicum RCMB 001018 (1), compounds 17e19, 21, 23e25, 44, 46 (at concentrations 1e5.0 mg/mL) showed higher inhibitory effect against Syncephalastrum racemosum RCMB 016001, compounds 18, 20, 22, 23, 43, 46 (at concentrations 1.0e5.0 mg/mL) showed higher inhibitory effect against Candida albicans RCMB 005003,compounds 17,18,20,22,24,43,44, 47 (at concentrations 1.0e5.0 mg/mL) showed higher inhibitory effect against Staphylococcus aureus RCMB 106-001 (1), compounds 18, 43, 44 (at concentrations 2.5e5.0 mg/mL) showed higher inhibitory effect against Pseudomonas aeruginosa compounds 17,19,21,24,25,46,47,49 (at concentrations 1e5.0 mg/mL) showed higher inhibitory effect against Bacillus subtilis RCMB 101-001, compounds 21, 43, 44 showed higher inhibitory effect against Escherichia coli RCMB 103-001 (at concentrations 1.0e2.5 mg/mL). On the other hand, compounds 17, 23, 24, 44, 47, 49 (at concentration 5.0 mg/mL) exhibited lower inhibitory effect against Penicillium italicum RCMB 001018 (1), compounds 17e20, 23e25, 46, 47, 49 (at concentration 5.0 mg/mL) exhibited lower inhibitory effect against Escherichia coli RCMB 103-001, when compared to compound 15.…”